Zydus Lifesciences Ltd.

Cadila Healthcare has informed that it enclosed a copy of press release dated October 22, 2021 titled ‘Zydus announces ‘first patient’ randomised in EVIDENCES-X TM Phase II(b) clinical trial of Saroglitazar Mg in NASH’.

The above information is a part of company’s filings submitted to BSE.